Clinical Trial Update: Clinical Study of Albumin-paclitaxel Combined With Apatinib and Camrelizumab in Advanced Gastric Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating albumin-paclitaxel combined with apatinib and camrelizumab in advanced gastric cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Albumin Paclitaxel (nab-paclitaxel)
• Apatinib (apatinib)
• Camrelizumab (camrelizumab)

Snippet

Sponsor: China Medical University, China | Conditions: Advanced Gastric Cancer | Phase 1, Phase 2 | Status: UNKNOWN